Schonfeld Strategic Advisors LLC Cabaletta Bio, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 194,037 shares of CABA stock, worth $842,120. This represents 0.01% of its overall portfolio holdings.
Number of Shares
194,037
Previous 317,520
38.89%
Holding current value
$842,120
Previous $5.42 Million
73.21%
% of portfolio
0.01%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
147Shares Held
50.2MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.55MShares$24.1 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$20.6 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$16.8 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$13.2 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$11.4 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $126M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...